These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 14711922)

  • 1. Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis.
    Vegni FE; Corradini C; Privitera G
    N Engl J Med; 2004 Jan; 350(2):189-92; author reply 189-92. PubMed ID: 14711922
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients.
    Seminari E; Castagna A; Soldarini A; Galli L; Fusetti G; Dorigatti F; Hasson H; Danise A; Guffanti M; Lazzarin A; Rubinacci A
    HIV Med; 2005 May; 6(3):145-50. PubMed ID: 15876279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone.
    Han KO; Choi JT; Choi HA; Moon IG; Yim CH; Park WK; Yoon HK; Han IK
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):349-53. PubMed ID: 15730418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoprotegerin to soluble receptor activator of nuclear factor kappa-B ligand ratio is reduced in patients with thalassaemia-related osteoporosis who receive vitamin D3.
    Voskaridou E; Terpos E
    Eur J Haematol; 2005 Apr; 74(4):359-61. PubMed ID: 15777350
    [No Abstract]   [Full Text] [Related]  

  • 5. Transforming growth factor beta1 and prostaglandin E2 concentrations are associated with bone formation markers in ulcerative colitis patients.
    Wiercinska-Drapalo A; Jaroszewicz J; Tarasow E; Flisiak R; Prokopowicz D
    Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):160-8. PubMed ID: 16303613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maturation-state dependent response of human periodontal ligament cells to an intermittent parathyroid hormone exposure in vitro.
    Lossdörfer S; Stier S; Götz W; Jäger A
    J Periodontal Res; 2006 Feb; 41(1):62-72. PubMed ID: 16409257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in osteoprotegerin/RANKL system, bone mineral density, and bone biochemicals markers in patients with recent spinal cord injury.
    Maïmoun L; Couret I; Mariano-Goulart D; Dupuy AM; Micallef JP; Peruchon E; Ohanna F; Cristol JP; Rossi M; Leroux JL
    Calcif Tissue Int; 2005 Jun; 76(6):404-11. PubMed ID: 15812577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RANKL/OPG system and bone mineral density in patients with chronic liver disease.
    Moschen AR; Kaser A; Stadlmann S; Millonig G; Kaser S; Mühllechner P; Habior A; Graziadei I; Vogel W; Tilg H
    J Hepatol; 2005 Dec; 43(6):973-83. PubMed ID: 16143421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in RANKL/OPG/RANK gene expression in peripheral mononuclear cells following treatment with estrogen or raloxifene.
    Bashir A; Mak YT; Sankaralingam S; Cheung J; McGowan NW; Grigoriadis AE; Fogelman I; Hampson G
    Steroids; 2005 Dec; 70(13):847-55. PubMed ID: 16005483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease.
    García-Valdecasas-Campelo E; González-Reimers E; Santolaria-Fernández F; De la Vega-Prieto MJ; Milena-Abril A; Sánchez-Pérez MJ; Martínez-Riera A; Gómez-Rodríguez Mde L
    Alcohol Alcohol; 2006; 41(3):261-6. PubMed ID: 16476762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regulation of bone mineralization by parathyroid hormone].
    Shimizu M; Tamura T
    Clin Calcium; 2004 Jun; 14(6):70-5. PubMed ID: 15577058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biochemical markers in bone metastasis].
    Hashimoto T; Abe M; Matsumoto T
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1027-33. PubMed ID: 15272580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and prognostic value of serum osteoprotegerin in multiple myeloma.
    Depil S; Mathiot C; Leleu X; Moreau AS; Faucompré JL; Hennache B; Bauters F; Bataille R; Facon T
    Br J Haematol; 2005 Jun; 129(5):706-7. PubMed ID: 15916694
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher disease.
    Magal I; Lebel E; Altarescu G; Itzchaki M; Rudensky B; Foldes AJ; Zimran A; Elstein D
    Br J Haematol; 2006 Apr; 133(1):93-7. PubMed ID: 16512834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeleton key to vascular disease.
    Demer LL; Abedin M
    J Am Coll Cardiol; 2004 Nov; 44(10):1977-9. PubMed ID: 15542279
    [No Abstract]   [Full Text] [Related]  

  • 16. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
    Stilgren LS; Rettmer E; Eriksen EF; Hegedüs L; Beck-Nielsen H; Abrahamsen B
    Bone; 2004 Jul; 35(1):256-65. PubMed ID: 15207766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correspondence re: A. Lipton et al., Serum osteoprotegerin levels in healthy controls and cancer patients. Clin. Cancer Res., 8: 2306-2310, 2002.
    Dovio A; Sartori ML; Angeli A
    Clin Cancer Res; 2003 Jun; 9(6):2384-5; author reply 2386. PubMed ID: 12796409
    [No Abstract]   [Full Text] [Related]  

  • 18. Osteoprotegerin in the inner ear may inhibit bone remodeling in the otic capsule.
    Zehnder AF; Kristiansen AG; Adams JC; Merchant SN; McKenna MJ
    Laryngoscope; 2005 Jan; 115(1):172-7. PubMed ID: 15630389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum osteoprotegerin level in older and diabetic hemodialysis patients.
    Doi S; Yorioka N; Masaki T; Ito T; Shigemoto K; Harada S
    Ther Apher Dial; 2004 Aug; 8(4):335-9. PubMed ID: 15274686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased osteoprotegerin and decreased pyridinoline levels in patients with ankylosing spondylitis: comment on the article by Gratacós et al.
    Golmia RP; Sousa BD; Scheinberg MA
    Arthritis Rheum; 2002 Dec; 46(12):3390-1; author reply 3392. PubMed ID: 12483748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.